Vasopressor resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) |
Ahmed Zaghw (talk | contribs) |
||
Line 23: | Line 23: | ||
{{Family tree | | | | | B01 | | B02 | | B03 | | B04 | | B05 | |B01='''Norepinephrine''' |B02='''Dopamine''' |B03='''Vasopressin''' |B04='''Phenylephrine'''|B05='''Dobutamine''' }} | {{Family tree | | | | | B01 | | B02 | | B03 | | B04 | | B05 | |B01='''Norepinephrine''' |B02='''Dopamine''' |B03='''Vasopressin''' |B04='''Phenylephrine'''|B05='''Dobutamine''' }} | ||
{{Family tree | | | | | |!| | | |!| | | |!| | | |!| | | |!| | |}} | {{Family tree | | | | | |!| | | |!| | | |!| | | |!| | | |!| | |}} | ||
{{Family tree | C01 | | C02 | | C03 | | C04 | | C05 | | C06 | |C01= '''Mechanism of action''' |C02= Mainly α1 (Vasoconstrictive) <br> β1 (↑contractility) |C03= Mainly β1(↑contractility) <br> α1(Vasoconstrictive)|C04= V<sub></sub>1 receptor of GIT vasculatures <br> Antidiuretic effects |C05= Pure α1 (Vasoconstrictive) <br> No β1 |C06= Mainly β1 (↑contractility) <br> β2 arterial smooth muscle (Hypotensive) }} | {{Family tree | C01 | | C02 | | C03 | | C04 | | C05 | | C06 | |C01= '''Mechanism of action''' |C02= *Mainly α1 (Vasoconstrictive) <br> *β1 (↑contractility) |C03= *Mainly β1(↑contractility) <br> *α1(Vasoconstrictive)|C04= *V<sub></sub>1 receptor of GIT vasculatures <br> *Antidiuretic effects |C05= *Pure α1 (Vasoconstrictive) <br> *No β1 |C06= *Mainly β1 (↑contractility) <br> *β2 arterial smooth muscle (Hypotensive) }} | ||
{{Family tree | | | | | |!| | | |!| | | |!| | | |!| | | |!| | |}} | {{Family tree | | | | | |!| | | |!| | | |!| | | |!| | | |!| | |}} | ||
{{Family tree | D01 | | D02 | | D03 | | D04 | | D05 | | D06 | |D01= '''Indication'''}} | {{Family tree | D01 | | D02 | | D03 | | D04 | | D05 | | D06 | |D01= '''Indication'''}} |
Revision as of 21:18, 5 December 2013
Sepsis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Vasopressor resident survival guide On the Web |
American Roentgen Ray Society Images of Vasopressor resident survival guide |
Risk calculators and risk factors for Vasopressor resident survival guide |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Definition
Causes
Life Threatening Causes
Common Causes
Prognosis
Management
Vasopressors | |||||||||||||||||||||||||||||||||||||||||||||||||
Norepinephrine | Dopamine | Vasopressin | Phenylephrine | Dobutamine | |||||||||||||||||||||||||||||||||||||||||||||
Mechanism of action | *Mainly α1 (Vasoconstrictive) *β1 (↑contractility) | *Mainly β1(↑contractility) *α1(Vasoconstrictive) | *V1 receptor of GIT vasculatures *Antidiuretic effects | *Pure α1 (Vasoconstrictive) *No β1 | *Mainly β1 (↑contractility) *β2 arterial smooth muscle (Hypotensive) | ||||||||||||||||||||||||||||||||||||||||||||
Indication | {{{ D02 }}} | {{{ D03 }}} | {{{ D04 }}} | {{{ D05 }}} | {{{ D06 }}} | ||||||||||||||||||||||||||||||||||||||||||||
Dose | {{{ E02 }}} | {{{ E03 }}} | {{{ E04 }}} | {{{ E05 }}} | {{{ E06 }}} | ||||||||||||||||||||||||||||||||||||||||||||
Complications | {{{ F02 }}} | {{{ F03 }}} | {{{ F04 }}} | {{{ F05 }}} | {{{ F06 }}} | ||||||||||||||||||||||||||||||||||||||||||||
Cautions | {{{ G02 }}} | {{{ G03 }}} | {{{ G04 }}} | {{{ G05 }}} | {{{ G06 }}} | ||||||||||||||||||||||||||||||||||||||||||||
Do's
- Assess the cause of shock
- Always volume fluid resuscitation first
- Norepinephrine in undifferentiated shock.